Probability bound analysis: A novel approach for quantifying parameter uncertainty in decision-analytic modeling and cost-effectiveness analysis

被引:2
|
作者
Iskandar, Rowan [1 ,2 ]
机构
[1] Swiss Inst Translat & Entrepreneurial Med Sitem I, Ctr Excellence Decis Analyt Modeling & Hlth Econ, Bern, Switzerland
[2] Brown Univ, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA
基金
欧盟地平线“2020”;
关键词
cost-effectiveness analysis; decision-analytic modeling; parameter uncertainty; probability bound analysis; probability box; uncertainty quantification; TECHNOLOGY; RECOMMENDATIONS; PROPAGATION; SENSITIVITY; CONDUCT; HEALTH;
D O I
10.1002/sim.9195
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Decisions about health interventions are often made using limited evidence. Mathematical models used to inform such decisions often include uncertainty analysis to account for the effect of uncertainty in the current evidence base on decision-relevant quantities. However, current uncertainty quantification methodologies, including probabilistic sensitivity analysis (PSA), require modelers to specify a precise probability distribution to represent the uncertainty of a model parameter. This study introduces a novel approach for representing and propagating parameter uncertainty, probability bounds analysis (PBA), where the uncertainty about the unknown probability distribution of a model parameter is expressed in terms of an interval bounded by lower and upper bounds on the unknown cumulative distribution function (p-box) and without assuming a particular form of the distribution function. We give the formulas of the p-boxes for common situations (given combinations of data on minimum, maximum, median, mean, or standard deviation), describe an approach to propagate p-boxes into a black-box mathematical model, and introduce an approach for decision-making based on the results of PBA. We demonstrate the characteristics and utility of PBA vs PSA using two case studies. In sum, this study provides modelers with practical tools to conduct parameter uncertainty quantification given the constraints of available data and with the fewest assumptions.
引用
收藏
页码:6501 / 6522
页数:22
相关论文
共 50 条
  • [1] Classification of evidence in decision-analytic models of cost-effectiveness: A content analysis of published reports
    Paisley, Suzy
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (04) : 458 - 462
  • [2] Primary asthma prevention amongst children - A cost-effectiveness analysis in a decision-analytic framework
    Ramos, G. Feljandro
    Kuiper, Sandra
    van Asselt, Antoinette D. I.
    Dompeling, Edward
    Maas, Tanja
    Severens, Johan L.
    Knottnerus, J. Andre
    van Schayck, Onno C. P.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [3] Combining a Budgetary-Impact Analysis and a Cost-Effectiveness Analysis Using Decision-Analytic Modelling Techniques
    Mark J.C. Nuijten
    Frans Rutten
    [J]. PharmacoEconomics, 2002, 20 : 855 - 867
  • [4] Combining a budgetary-impact analysis and a cost-effectiveness analysis using decision-analytic modelling techniques
    Nuijten, MJC
    Rutten, F
    [J]. PHARMACOECONOMICS, 2002, 20 (12) : 855 - 867
  • [5] Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes
    Smare, Caitlin
    Lakhdari, Khalid
    Doan, Justin
    Posnett, John
    Johal, Sukhvinder
    [J]. PHARMACOECONOMICS, 2020, 38 (01) : 97 - 108
  • [6] Spinal cord stimulation for failed back surgery syndrome: A decision-analytic model and cost-effectiveness analysis
    Taylor, RJ
    Taylor, RS
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2005, 21 (03) : 351 - 358
  • [7] Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes
    Caitlin Smare
    Khalid Lakhdari
    Justin Doan
    John Posnett
    Sukhvinder Johal
    [J]. PharmacoEconomics, 2020, 38 : 97 - 108
  • [8] Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model
    Ramos, G. Feljandro P.
    van Asselt, Antoinette D. I.
    Kuiper, Sandra
    Severens, Johan L.
    Maas, Tanja
    Dompeling, Edward
    Knottnerus, J. Andre
    van Schayck, Onno C. P.
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (08): : 869 - 883
  • [9] Cost-effectiveness of abciximab after coronary stenting: A decision-analytic model
    Rodriguez, O
    Cutlip, DE
    Kuntz, RE
    Cohen, DJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 51A - 51A
  • [10] COST-EFFECTIVENESS OF TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION: A DECISION-ANALYTIC MODEL
    Amin, Amit P.
    Marso, Steven P.
    Chhatriwalla, Adnan
    Safley, David
    Kennedy, Kevin
    House, John
    Mills, Rebecca
    Salisbury, Adam
    Spertus, John
    Cohen, David
    Baklanov, Dmitri
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E338 - E338